Blue Horseshoe Stocks: Cannabis Commentary & More

NeoPhotonics Corp. NPTN

We’re always bargain hunting for stocks that have been recently beaten back to what appear to be unsustainably low levels, and we’re observing one heck of a double bottom setup on NPTN at the present time.

Twice now the stock has touched and rebounded off of the mid-$4 range, with the annual low coming in at 4.56. We’re going to want to place NPTN on watch in sessions to come and look for the stock to establish higher levels of support.



Valeant Pharmaceuticals International, Inc. VRX

It’s been awhile since we had a look at VRX, and as it turns out, this is another stock that looks ready to start a trend off of a recent relative low.

VRX is gapping up considerably into the $14-range this morning on the heels of a solid earnings beat. We’re going to signal a range of options contracts to watch for some possible dip-and-rip activity. This is just the type of setup we routinely look for, and we’ll be tracking the VRX Weekly $13-14 Calls for the remainder of the week.



Cannabis Commentary

It has been a slow year in general for many domestic cannabis stocks, due, at least in part, to a DOJ led by outspoken marijuana opponent Jeff Sessions. It has created an environment of uncertainty pertaining to the federal government’s likelihood of creating problems for marijuana businesses, even in states where voters have officially spoken and legalized the plant. The marijuana movement is here to stay, but at present, is dealing with this roadblock of sorts.

That doesn’t mean our interest in the sector has diminished. In fact, we’re as exuberant about the future of the cannabis industry as we ever were. North of the Border, Canadians will enact a nationwide end to prohibition just 8 months from now.

The World Anti-Doping Agency, which was formed by the International Olympic Committee to police the use of performance enhancing drugs in athletics, also recently removed Cannabidiol (CBD) from its list of banned substances, opening up a huge market for the hemp-derived product.

Here are just a few of the cannabis plays that we track on a regular basis, and will continue to do so as we head into 2018, which we feel is going to be a big year for the industry and all of its subsectors. Maybe the biggest one yet!

MJNA, TRTC, MJTK, AGTK, GRNH, HEMP, ACBFF, APHQF,  TWMJF, CBIS, XXII,


Extended Watchlist:
TXMD, EVEP, DXTR, COLL, CRC

Blue Horseshoe Stocks: PIXY Review & More

ShiftPixy, Inc. PIXY

As we were mentioning on Monday morning, we included PIXY in Friday’s report on its first ever trading day. Generally speaking we don’t tend to cast our lot in with brand new IPO’s, but a trusted source in our network gave us a heads-up on PIXY, and didn’t let us down.

We of course passed it along to our readers immediately in our premarket report on Friday, and the stock, after two trading days has made some really nice progress.

From the initial opening price of 6.30 we observed in PIXY, it went on to hit a high of 9.70 to kick off the short trading week on Monday. That marks a two-day swing of 54% for this newly-trading juggernaut. We’ll continue to be on the lookout for PIXY to keep recording higher base levels of support.


Opexa Therapeutics, Inc. OPXA

An honorable mention from Monday’s report is OPXA, especially considering that sessions just prior to a holiday break are typically low-key affairs.

The stock put up a solid intraday performance, running 35% from a low of a dollar up to 1.35, and pulling back into the close at 1.15. However, premarket activity this morning has seen the stock trade back to just below Monday’s high. This is one we’ll want to keep on our radar for the time being.


Aphria, Inc. APHQF

We’ve been familiar with APHQF for quite a time, but today will be the first occasion we’ve actually mentioned it in our reports.

Today, we wanted to point out that the company released two PR’s yesterday, the more significant of which was the announcement of a 1-year cannabis supply deal with a licensed Canadian medical provider which will bring upwards of $5M in revenue beginning midway through next year. We’ll provide links to both PR’s so you can check them out for yourself.

Aphria Inks Major Wholesale Supply Agreement With Scientus Pharma, Health Canada Licensed Dealer – 07/04

Tokyo Smoke to open Canadian flagship retail store on Queen Street West – 07/04


Extended Watchlist:
OTTV, CLSN, MSDI, MTBC, TOPS, GBR, FCEL